Effect of Classic Secondary Prevention in Type 2 MI: A Target Trial Emulation Study

NCT06736353 · clinicaltrials.gov ↗

COMPLETED

Status

14000

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction Type 2

Interventions

DRUG: Beta Blocker Therapy or No Therapy (Control)
DRUG: RAAS blocker Therapy or No therapy (Control)
DRUG: Statin Therapy or No Therapy (Control)
DRUG: Single Antiplatelet Therapy or No Therapy (Control)
DRUG: Dual Antiplatelet Therapy or No Therapy (Control)

Sponsor

Uppsala University